Fulvestrant FDA approval date

The FDA approved Fulvestrant (Faslodex) on 25 Apr 2002.

FDA approval date
25 Apr 2002

Drug identity checked against registry records

Also recorded as Faslodex

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2002-04-25DayFulvestrantFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021344", "applicant_as_listed_by_fda": "ASTRAZENECA", "brand_names": ["FASLODEX"], "active_ingredients": ["FULVESTRANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20020425", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026